West Pharmaceutical Services (WST) Assets Average (2010 - 2026)

West Pharmaceutical Services has disclosed Assets Average across 17 years of filings, most recently posting $4.2 billion for Q1 2026.

• Assets Average for Q1 2026 came in at $4.2 billion, up 15.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 billion (up 15.4% YoY), and the FY2025 annual result was $4.0 billion, up 5.89% from the prior year.
• Assets Average came in at $4.2 billion for Q1 2026 at West Pharmaceutical Services, roughly flat from $4.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $4.2 billion in Q1 2026 to a low of $3.3 billion in Q1 2022.
• The 5-year median for Assets Average is $3.7 billion (2023), against an average of $3.7 billion.
• Across the five-year window, Assets Average advanced 19.43% in 2022 and dropped 4.08% in 2024, its largest moves.
• West Pharmaceutical Services' Assets Average stood at $3.5 billion in 2022, then rose by 9.38% to $3.8 billion in 2023, then slipped by 3.5% to $3.7 billion in 2024, then advanced by 14.45% to $4.2 billion in 2025, then climbed by 0.05% to $4.2 billion in 2026.
• The last three Assets Average figures came in at $4.2 billion (Q1 2026), $4.2 billion (Q4 2025), and $4.0 billion (Q3 2025), per Business Quant data.